Kidder Stephen W Abbott Laboratories Transaction History

Kidder Stephen W

$313 Million
Q1 2025

A detailed history of Kidder Stephen W transactions in Abbott Laboratories stock. As of the latest transaction made, Kidder Stephen W holds 92,672 shares of ABT stock, worth $12.4 Million. This represents 3.93% of its overall portfolio holdings.

Number of Shares

92,672

Previous 92,696 0.03%

Holding current value

$12.4 Million

Previous $10.5 Million 17.25%

% of portfolio

3.93%

Previous 3.22%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$111.1 - $140.22 $2,666 - $3,365	-24 Reduced 0.03%	92,672 $12.3 Million
Q4 2024 Feb 12, 2025	BUY	$111.93 - $119.39 $26,975 - $28,772	241 Added 0.26%	92,696 $10.5 Million
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $10,407 - $12,285	-104 Reduced 0.11%	92,455 $10.5 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $100,730 - $112,440	1,000 Added 1.09%	92,559 $9.62 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $385,510 - $425,779	-3,520 Reduced 3.7%	91,559 $10.4 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $186,873 - $228,748	2,072 Added 2.23%	95,079 $10.5 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $126,577 - $151,871	1,325 Added 1.45%	93,007 $9.01 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $17,838 - $19,875	177 Added 0.19%	91,682 $10 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $26,152 - $30,782	-270 Reduced 0.29%	91,505 $9.27 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $269,970 - $316,716	2,840 Added 3.19%	91,775 $10.1 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $4,838 - $5,601	-50 Reduced 0.06%	88,935 $8.61 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $34,397 - $41,575	-337 Reduced 0.38%	88,985 $9.67 Million
Q1 2022 May 17, 2022	SELL	$114.02 - $139.04 $71,490 - $87,178	-627 Reduced 0.7%	89,322 $10.6 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $915,113 - $1.12 Million	-7,921 Reduced 8.09%	89,949 $12.7 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $131,125 - $145,063	-1,124 Reduced 1.14%	97,870 $11.6 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $164,609 - $193,768	1,556 Added 1.6%	98,994 $11.5 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $125,166 - $147,464	-1,150 Reduced 1.17%	97,438 $11.7 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $559,860 - $610,087	-5,332 Reduced 5.13%	98,588 $10.8 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $162,935 - $197,873	-1,778 Reduced 1.68%	103,920 $11.3 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $153,140 - $196,000	-2,000 Reduced 1.86%	105,698 $9.66 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $132,738 - $194,100	-2,113 Reduced 1.92%	107,698 $8.5 Million
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $157,491 - $175,324	-2,006 Reduced 1.79%	109,811 $9.54 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $49,922 - $54,131	-610 Reduced 0.54%	111,817 $9.36 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $327,741 - $382,245	-4,497 Reduced 3.85%	112,427 $9.46 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $709,547 - $857,842	-10,715 Reduced 8.39%	116,924 $9.35 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $234,442 - $265,589	-3,576 Reduced 2.73%	127,639 $9.23 Million
Q3 2018 Oct 15, 2018	SELL	$60.81 - $73.36 $223,172 - $269,231	-3,670 Reduced 2.72%	131,215 $9.63 Million
Q2 2018 Jul 30, 2018	SELL	$57.57 - $63.54 $99,883 - $110,241	-1,735 Reduced 1.27%	134,885 $8.23 Million
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $211,518 - $239,147	-3,759 Reduced 2.68%	136,620 $8.19 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $76,762 - $82,182	1,430 Added 1.03%	140,379 $8.01 Million
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $6.68 Million - $7.45 Million	138,949	138,949 $7.41 Million

Others Institutions Holding ABT

# of Institutions

3,542

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $235B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kidder Stephen W, based on Form 13F filings with the SEC.

News

Stay updated on Kidder Stephen W with notifications on news.

Account